BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15256447)

  • 41. Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts.
    Hartman J; Lindberg K; Morani A; Inzunza J; Ström A; Gustafsson JA
    Cancer Res; 2006 Dec; 66(23):11207-13. PubMed ID: 17145865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet-derived growth factors and receptors in the rat corpus luteum: localization and identification of an effect on luteogenesis.
    Sleer LS; Taylor CC
    Biol Reprod; 2007 Mar; 76(3):391-400. PubMed ID: 17108335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microbiological approach to the treatment of brain tumors].
    Kuratsu J; Ushio Y
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):195-200. PubMed ID: 1992913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis.
    Ho IA; Toh HC; Ng WH; Teo YL; Guo CM; Hui KM; Lam PY
    Stem Cells; 2013 Jan; 31(1):146-55. PubMed ID: 23034897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.
    Huang Y; Hoffman C; Rajappa P; Kim JH; Hu W; Huse J; Tang Z; Li X; Weksler B; Bromberg J; Lyden DC; Greenfield JP
    Cancer Res; 2014 Feb; 74(4):1011-21. PubMed ID: 24371228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.
    Lindberg N; Kastemar M; Olofsson T; Smits A; Uhrbom L
    Oncogene; 2009 Jun; 28(23):2266-75. PubMed ID: 19421151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.
    Funa K; Uramoto H
    Acta Biochim Pol; 2003; 50(3):647-58. PubMed ID: 14515146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.
    Ostman A
    Cytokine Growth Factor Rev; 2004 Aug; 15(4):275-86. PubMed ID: 15207817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation.
    Ran C; Liu H; Hitoshi Y; Israel MA
    Cancer Res; 2013 Mar; 73(6):1831-43. PubMed ID: 23322009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glioma-Derived Platelet-Derived Growth Factor-BB Recruits Oligodendrocyte Progenitor Cells via Platelet-Derived Growth Factor Receptor-α and Remodels Cancer Stroma.
    Zheng Y; Yamamoto S; Ishii Y; Sang Y; Hamashima T; Van De N; Nishizono H; Inoue R; Mori H; Sasahara M
    Am J Pathol; 2016 May; 186(5):1081-91. PubMed ID: 26945107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
    Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
    Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Plasticity of malignant tumor cells].
    Kofman AV
    Tsitologiia; 2011; 53(10):832-3. PubMed ID: 22232941
    [No Abstract]   [Full Text] [Related]  

  • 54. Overexpression of oncogene products can cause tumor progression without parenchymal infiltration in the rat brain.
    Schwartz MS; Morris J; Sarid J
    Cancer Res; 1991 Jul; 51(13):3595-601. PubMed ID: 1675934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression.
    Reis M; Czupalla CJ; Ziegler N; Devraj K; Zinke J; Seidel S; Heck R; Thom S; Macas J; Bockamp E; Fruttiger M; Taketo MM; Dimmeler S; Plate KH; Liebner S
    J Exp Med; 2012 Aug; 209(9):1611-27. PubMed ID: 22908324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas.
    Mauro A; Bulfone A; Turco E; Schiffer D
    Childs Nerv Syst; 1991 Dec; 7(8):432-6. PubMed ID: 1665101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
    Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
    Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trials of small molecule inhibitors in high-grade glioma.
    Day SE; Waziri A
    Neurosurg Clin N Am; 2012 Jul; 23(3):407-16. PubMed ID: 22748653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A cell-autonomous positive-signaling circuit associated with the PDGF-NO-ID4-regulatory axis in glioblastoma cells.
    Eun K; Jeon HM; Kim SO; Choi SH; Lee SY; Jin X; Kim SC; Kim H
    Biochem Biophys Res Commun; 2017 Apr; 486(2):564-570. PubMed ID: 28327358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma.
    Onishi M; Ichikawa T; Kurozumi K; Inoue S; Maruo T; Otani Y; Fujii K; Ishida J; Shimazu Y; Yoshida K; Michiue H; Antonio Chiocca E; Date I
    Brain Tumor Pathol; 2015 Jul; 32(3):184-94. PubMed ID: 25697644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.